Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$11.36 - $16.99 $3.82 Million - $5.72 Million
-336,423 Reduced 66.09%
172,600 $2.6 Billion
Q1 2022

May 16, 2022

SELL
$7.99 - $16.93 $7 - $16
-1 Reduced -0.0%
509,023 $4.78 Million
Q4 2021

Feb 14, 2022

BUY
$13.7 - $35.0 $6.97 Million - $17.8 Million
509,024 New
509,024 $8.71 Million

Others Institutions Holding TRDA

About Entrada Therapeutics, Inc.


  • Ticker TRDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,368,500
  • Market Cap $551M
  • Description
  • Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...
More about TRDA
Track This Portfolio

Track 72 Investment Holdings, LLC Portfolio

Follow 72 Investment Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 72 Investment Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 72 Investment Holdings, LLC with notifications on news.